勃林格殷格翰-礼来糖尿病联盟近日在美国监管方面收获喜讯,双方合作开发的2型糖尿病复方新药Synjardy XR(empagliflozin/盐酸二甲双胍缓释片)获得美国食品和药物管理局(FDA)批准用于2型糖尿病(T2D)成人患者的治疗,该药每日口服一次,适用于...
Brand name: Synjardy What is Synjardy (empagliflozin and metformin), and how does it work? Synjardy (empagliflozin and metformin) is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. Synjardy may be used alone or with other medications. Synjardy belongs to a class...
美国FDA了批准SYNJARDY-XR(empagliflozin和盐酸二甲双胍缓释片)用于治疗2型糖尿病成人。当配合饮食和运动,SYNJARDY-XR可有效改善成年2型糖尿病成人患者的血糖水平,它由Boehringer Ingelheim和礼来公司(Eli Lilly and Company)合作上市。 全世界范围约有4.15亿人患有糖尿病,它是一种由于身体不适当产生胰岛素或对胰岛素抵抗...
When does the Synjardy coupon expire? Are there any terms and conditions for using the Synjardy coupon? How much money can I save with the Synjardy coupon? Do I need to enroll in a patient assistance program to use the Synjardy coupon? Are there online pharmacies that accept the Synjardy co...
Synjardy是一种复方单片制剂,每日口服2次,有4种剂量规格,适用于多种2型糖尿病患者,包括最大耐受剂量二甲双胍单药治疗时仍不能充分控制血糖水平的患者、二甲双胍联合其他降糖药(包括胰岛素)仍不能充分控制血糖水平的患者,以及正在接受empagliflozin和二甲双胍联合治疗的2型糖尿病患者。
FDA已经批准Synjardy XR用于控制2型糖尿病患者的血糖水平,Synjardy由勃林格殷格翰和礼来公司共同研发,是SGLT2抑制剂Empagliflozin(恩格列净)和二甲双胍复方缓释片。 Synjardy可以在饮食和运动过程中服用,用于改善成人2型糖尿病患者的血糖水平,此时Empagliflozin和二甲双胍都可以起到降糖作用。
勃林格殷格翰-礼来糖尿病联盟近日在欧盟监管方面收获喜讯,双方合作研发的2性糖尿病复方新药Synjardy(empagliflozin/盐酸二甲双胍)获欧盟委员会(EC)批准,用于2型糖尿病(T2D)成人患者的治疗。Synjardy每日口服2次,该药有4种剂量规格(empagliflozin/二甲双胍):5mg/850mg,5mg/1000mg,12.5mg/850mg,12.5mg/1000mg。Synjar...
Synjardy (empagliflozin/metformin) is commonly used to help lower blood sugar levels in people with type 2 diabetes. Synjardy is also used in people with type 2 diabetes and either heart disease or heart failure to reduce your chance of the following complications. Dying from heart problems Hospi...
2性糖尿病复方新药Synjardy(empagliflozin/盐酸二甲双胍)获得欧盟委员会(EC)的批准。现有5mg/850mg,5mg/1000mg,12.5mg/850mg,12.5mg/1000mg
003SYNJARDYEMPAGLIFLOZIN; METFORMIN HYDROCHLORIDETABLET;ORAL12.5MG;500MGYesNoAB2015/08/26Prescription 004SYNJARDYEMPAGLIFLOZIN; METFORMIN HYDROCHLORIDETABLET;ORAL12.5MG;1GMYesYesAB2015/08/26Prescription 批准日期,申请提交历史,通知信,药品说明书,审评文件等信息 ...